** Stifel starts Sectra SECTb.ST with "sell" citing "very
high" risk of contracting valuation multiples for the Swedish
technology firm
** "Sectra is far too expensive for our taste," the
brokerage says
** The group is currently trading at its largest ever
premium compared to the broader software market, Stifel says,
with valuation multiples which have not come down since 2020
** Sectra is very well positioned to gain market share in
the imaging IT market and to outpace competition in digital
pathology, which should lead to mid-teens growth for several
years to come, the brokerage says
** Despite that, Stifel does not expect significant margin
expansion in the coming years, which will limit EBITDA growth
** The stock trades down 10% at 0922 GMT
(Reporting by Jagoda Darlak)
((jagoda.darlak@tr.com))